vs
Side-by-side financial comparison of Dexcom (DXCM) and Triumph Financial, Inc. (TFIN). Click either name above to swap in a different company.
Triumph Financial, Inc. is the larger business by last-quarter revenue ($2.4B vs $1.3B, roughly 1.9× Dexcom). Dexcom runs the higher net margin — 21.2% vs 0.3%, a 21.0% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 2.6%). Over the past eight quarters, Triumph Financial, Inc.'s revenue compounded faster (377.6% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
The Triumph Motor Company was a British car and motor manufacturing company in the 19th and 20th centuries. The marque had its origins in 1885 when Siegfried Bettmann of Nuremberg formed S. Bettmann & Co. and started importing bicycles from Europe and selling them under his own trade name in London. The trade name became "Triumph" the following year, and in 1887 Bettmann was joined by a partner, Moritz Schulte, also from Germany. In 1889, the businessmen started producing their own bicycles i...
DXCM vs TFIN — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $2.4B |
| Net Profit | $267.3M | $6.4M |
| Gross Margin | 62.9% | 86.1% |
| Operating Margin | 25.6% | — |
| Net Margin | 21.2% | 0.3% |
| Revenue YoY | 21.6% | 2.6% |
| Net Profit YoY | 153.6% | -66.9% |
| EPS (diluted) | $0.67 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $2.4B | ||
| Q4 25 | $1.3B | $120.1M | ||
| Q3 25 | $1.2B | $109.3M | ||
| Q2 25 | $1.2B | $108.1M | ||
| Q1 25 | $1.0B | $101.6M | ||
| Q4 24 | $1.1B | $103.6M | ||
| Q3 24 | $994.2M | $106.2M | ||
| Q2 24 | $1.0B | $105.1M |
| Q1 26 | $267.3M | $6.4M | ||
| Q4 25 | $267.3M | — | ||
| Q3 25 | $283.8M | $1.7M | ||
| Q2 25 | $179.8M | $4.4M | ||
| Q1 25 | $105.4M | $17.0K | ||
| Q4 24 | $151.7M | $3.8M | ||
| Q3 24 | $134.6M | $5.3M | ||
| Q2 24 | $143.5M | $2.7M |
| Q1 26 | 62.9% | 86.1% | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | — | ||
| Q3 25 | 20.1% | 1.2% | ||
| Q2 25 | 18.4% | 7.3% | ||
| Q1 25 | 12.9% | 0.1% | ||
| Q4 24 | 17.0% | 5.6% | ||
| Q3 24 | 15.3% | 5.9% | ||
| Q2 24 | 15.7% | 3.4% |
| Q1 26 | 21.2% | 0.3% | ||
| Q4 25 | 21.2% | — | ||
| Q3 25 | 23.5% | 1.6% | ||
| Q2 25 | 15.5% | 4.1% | ||
| Q1 25 | 10.2% | 0.0% | ||
| Q4 24 | 13.6% | 3.7% | ||
| Q3 24 | 13.5% | 5.0% | ||
| Q2 24 | 14.3% | 2.6% |
| Q1 26 | $0.67 | $0.23 | ||
| Q4 25 | $0.67 | — | ||
| Q3 25 | $0.70 | $0.04 | ||
| Q2 25 | $0.45 | $0.15 | ||
| Q1 25 | $0.27 | $-0.03 | ||
| Q4 24 | $0.37 | $0.13 | ||
| Q3 24 | $0.34 | $0.19 | ||
| Q2 24 | $0.35 | $0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $950.7M |
| Total Assets | $6.3B | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $248.5M | ||
| Q3 25 | $1.8B | $147.2M | ||
| Q2 25 | $1.2B | $282.3M | ||
| Q1 25 | $904.9M | $502.9M | ||
| Q4 24 | $606.1M | $330.1M | ||
| Q3 24 | $621.2M | $489.3M | ||
| Q2 24 | $939.2M | $500.7M |
| Q1 26 | $2.7B | $950.7M | ||
| Q4 25 | $2.7B | $941.8M | ||
| Q3 25 | $2.7B | $919.3M | ||
| Q2 25 | $2.6B | $912.4M | ||
| Q1 25 | $2.3B | $893.9M | ||
| Q4 24 | $2.1B | $890.9M | ||
| Q3 24 | $2.0B | $885.8M | ||
| Q2 24 | $2.4B | $874.2M |
| Q1 26 | $6.3B | $6.9B | ||
| Q4 25 | $6.3B | $6.4B | ||
| Q3 25 | $7.5B | $6.4B | ||
| Q2 25 | $7.3B | $6.5B | ||
| Q1 25 | $6.8B | $6.3B | ||
| Q4 24 | $6.5B | $5.9B | ||
| Q3 24 | $6.4B | $5.9B | ||
| Q2 24 | $6.8B | $5.8B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
